Oncology Centres

For oncology centres serving PMI- and state-funded patients, KINsight provides a clinically governed, low-friction infrastructure for systematically identifying and MDT-managing inherited genetic causes of cancer (IGCCs), including appropriate germline testing, surveillance, and family cascade. Early identification reduces late-stage diagnosis while delivering substantial downstream cost avoidance – giving centres clear, defensible evidence of value creation and significantly strengthening their negotiating position with insurers and state funders.